| Abstract: The present invention relates to the identification of genetic markers
patients with high risk B-precursor acute lymphoblastic leukemia (B-ALL)
and associated methods and their relationship to therapeutic outcome. The
present invention also relates to diagnostic, prognostic and related
methods using these genetic markers, as well as kits which provide
microchips and/or immunoreagents for performing analysis on leukemia
patients. |
| Filed: 11/14/2008 |
| Application Number: 12/734542 |
| This invention was made with Government support under Contract No. DE-NA0003525 awarded by the United States Department of Energy/National Nuclear Security Administration. The Government has certain rights in the invention. |
| Attribution for Derwent World Patents Index Records published on Sandia ® Clarivate. All rights reserved. Republication or redistribution of Clarivate content, including by framing or similar means, is prohibited without the prior written consent of Clarivate. Clarivate and its logo, as well as all other trademarks used herein are trademarks of their respective owners and used under license. |